Norges Bank Vir Biotechnology, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $220,507 - $365,874	28,900 New	28,900 $257,000
Q4 2023 Feb 09, 2024	BUY	$7.76 - $10.29 $247,644 - $328,384	31,913 New	31,913 $321,000
Q3 2023 Nov 13, 2024	BUY	$9.14 - $24.62 $9.96 Million - $26.8 Million	1,089,537 New	1,089,537 $10.2 Million
Q3 2023 Nov 13, 2023	SELL	$9.14 - $24.62 $5.63 Million - $15.2 Million	-615,867 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$23.2 - $27.29 $17.4 Million - $20.4 Million	748,250 Added 2589.1%	777,150 $19.1 Million
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $13.9 Million - $16.3 Million	-598,364 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$22.26 - $30.85 $14.2 Million - $19.6 Million	636,950 New	636,950 $14.8 Million
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $14.5 Million - $20.6 Million	728,560 New	728,560 $18.4 Million
Q3 2022 Nov 13, 2023	BUY	$18.26 - $31.1 $11.2 Million - $19.2 Million	615,867 New	615,867 $11.9 Million
Q2 2022 Aug 14, 2023	BUY	$19.08 - $26.7 $11.4 Million - $16 Million	598,364 New	598,364 $15.2 Million
Q1 2022 May 12, 2023	SELL	$21.19 - $40.01 $3.72 Million - $7.02 Million	-175,443 Reduced 24.08%	553,117 $14.2 Million
Q1 2022 May 09, 2022	SELL	$21.19 - $40.01 $10.5 Million - $19.9 Million	-497,420 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$30.97 - $54.03 $15.4 Million - $26.9 Million	497,420 New	497,420 $20.8 Million
Q3 2021 Nov 14, 2022	BUY	$34.9 - $54.54 $13.7 Million - $21.5 Million	393,669 New	393,669 $17.1 Million
Q3 2021 Nov 05, 2021	SELL	$34.9 - $54.54 $10.2 Million - $15.9 Million	-291,675 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$38.75 - $51.0 $11.3 Million - $14.9 Million	291,675 New	291,675 $13.8 Million
Q2 2021 Aug 10, 2021	SELL	$38.75 - $51.0 $19.6 Million - $25.8 Million	-505,527 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$26.34 - $83.07 $13.3 Million - $42 Million	505,527 New	505,527 $25.9 Million
Q1 2021 May 07, 2021	SELL	$26.34 - $83.07 $15 Million - $47.5 Million	-571,244 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$25.51 - $43.38 $14.6 Million - $24.8 Million	571,244 New	571,244 $15.3 Million
Q4 2020 Feb 10, 2021	SELL	$25.51 - $43.38 $16.3 Million - $27.7 Million	-639,338 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$28.28 - $53.6 $18.1 Million - $34.3 Million	639,338 New	639,338 $21.9 Million
Q3 2020 Nov 10, 2020	SELL	$28.28 - $53.6 $23 Million - $43.6 Million	-812,916 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$27.89 - $47.86 $22.7 Million - $38.9 Million	812,916 New	812,916 $33.3 Million
Q1 2020 May 08, 2020	SELL	$12.04 - $60.2 $301,000 - $1.51 Million	-25,000 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$11.83 - $15.85 $295,750 - $396,250	25,000 New	25,000 $314,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$123 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$122 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$97.2 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$41.6 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$26.4 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account